PUBLIC HEALTH IMPACT OF QUADRIVALENT HPV TYPES 6, 11, 16, 18 VACCINE IN SAO PAULO, BRAZIL USING A TRANSMISSION DYNAMIC MODEL

被引：0
|
作者：
Singhal, P. [1 ]
Tannus, G. [2 ]
Pillsbury, M. [1 ]
Dasbach, E. [3 ]
机构：
[1] Merck & Co Inc, West Point, PA USA
[2] Axia Bio, Sao Paulo, Brazil
[3] Merck Res Labs, N Wales, PA USA
来源：
VALUE IN HEALTH | 2011年 / 14卷 / 07期
关键词：
D O I：
10.1016/j.jval.2011.08.1190
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A450 / A450
页数：1
相关论文
共 50 条
  • [1] ESTIMATED HEALTH AND ECONOMIC IMPACT OF QUADRIVALENT HPV TYPES 6, 11, 16, 18 VACCINE IN BRAZIL USING A TRANSMISSION DYNAMIC MODEL
    Singhal, P. K.
    Tannus, G.
    Fonseca, M.
    Kawai, K.
    Dasbach, E.
    [J]. VALUE IN HEALTH, 2011, 14 (03) : A118 - A118
  • [2] ESTIMATED HEALTH AND ECONOMIC IMPACT OF QUADRIVALENT HPV TYPES 6, 11, 16, 18 VACCINE IN THAILAND USING A TRANSMISSION DYNAMIC MODEL
    Singhal, P. K.
    Termrungruanglert, W.
    Khemapech, N.
    Havanond, P.
    Taneepanichskul, S.
    [J]. VALUE IN HEALTH, 2010, 13 (07) : A541 - A541
  • [3] Estimated health and economic impact of quadrivalent HPV (types 6/11/16/18) vaccination in Brazil using a transmission dynamic model
    Kosuke Kawai
    Gabriela Tannus Branco de Araujo
    Marcelo Fonseca
    Matthew Pillsbury
    Puneet K Singhal
    [J]. BMC Infectious Diseases, 12
  • [4] Estimated health and economic impact of quadrivalent HPV (types 6/11/16/18) vaccination in Brazil using a transmission dynamic model
    Kawai, Kosuke
    Branco de Araujo, Gabriela Tannus
    Fonseca, Marcelo
    Pillsbury, Matthew
    Singhal, Puneet K.
    [J]. BMC INFECTIOUS DISEASES, 2012, 12
  • [5] Impact of a Quadrivalent HPV6/11/16/18 Vaccine in Mexican Women: Public Health Implications for the Region
    Lazcano-Ponce, Eduardo
    Perez, Gonzalo
    Cruz-Valdez, Aurelio
    Zamilpa, Laura
    Aranda-Flores, Carlos
    Hernandez-Nevarez, Pilar
    Luis Viramontes, Jose
    Salgado-Hernandez, Joaquin
    James, Margaret
    Lu, Shuang
    Sattler, Carlos
    Haupt, Richard M.
    Hernandez-Avila, Mauricio
    [J]. ARCHIVES OF MEDICAL RESEARCH, 2009, 40 (06) : 514 - 524
  • [6] Overview of the clinical development and results of a quadrivalent HPV (types 6, 11, 16, 18) vaccine
    Villa, Luisa Lina
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2007, 11 : S17 - S25
  • [7] THE HEALTH AND ECONOMIC IMPACT OF A QUADRIVALENT HUMAN PAPILLOMAVIRUS VACCINE (6/11/16/18) IN COLUMBIA: A TRANSMISSION DYNAMIC MODEL-BASED EVALUATION
    Kothari, S.
    Nwankwo, C.
    Pillsbury, M.
    Shcheprov, A.
    Posso, H.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A713 - A714
  • [8] Quadrivalent Human Papillomavirus (HPV) Types 6, 11, 16, 18 Vaccine for the Prevention of Genital Warts in Males
    Garnock-Jones, Karly P.
    Giuliano, Anna R.
    [J]. DRUGS IN R&D, 2012, 12 (04) : 235 - 238
  • [9] Quadrivalent Human Papillomavirus (HPV) Types 6, 11, 16, 18 Vaccine For the Prevention of Genital Warts in Males
    Garnock-Jones, Karly P.
    Giuliano, Anna R.
    [J]. DRUGS, 2011, 71 (05) : 591 - 602
  • [10] Clinical efficiency of quadrivalent HPV (types 6/11/16/18) vaccine in patients with recurrent respiratory papillomatosis
    Magdalena Chirilă
    Sorana D. Bolboacă
    [J]. European Archives of Oto-Rhino-Laryngology, 2014, 271 : 1135 - 1142
12345